Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Endocrine-Related Cancer|June 11, 2009
Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitroAlexander Gorshtein, Hadara Rubinfeld, Efrat Kendler, et al.
Molecular Biology Reports|February 11, 2024
Erythropoietin-producing hepatocellular receptor B6 is highly expressed in non-functioning pituitary neuroendocrine tumors and its expression correlates with tumor sizeHadara Rubinfeld, Zvi R Cohen, Uzi Bendavid, et al.
Molecular and Cellular Endocrinology|October 10, 2009
The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cellsSimona Grozinsky-Glasberg, Hadara Rubinfeld, Yardena Nordenberg, et al.
Science Signaling|April 12, 2018
The nuclear translocation of the kinases p38 and JNK promotes inflammation-induced cancerGalia Maik-Rachline, Elder Zehorai, Tamar Hanoch, et al.
Scientific Reports|February 23, 2017
Direct binding of MEK1 and MEK2 to AKT induces Foxo1 phosphorylation, cellular migration and metastasisShiri Procaccia, Merav Ordan, Izel Cohen, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 3, 2018
Gq-Induced Apoptosis is Mediated by AKT Inhibition That Leads to PKC-Induced JNK ActivationGuy Nadel, Zhong Yao, Ido Ben-Ami, et al.
Current Biology : CB|November 9, 2013
ERK as a model for systems biology of enzyme kinetics in cellsAlan S Futran, A James Link, Rony Seger, et al.
Endocrinology|October 20, 2011
Heparanase is highly expressed and regulates proliferation in GH-secreting pituitary tumor cellsHadara Rubinfeld, Victoria Cohen-Kaplan, Dvora Nass, et al.
Cancer Research|January 14, 2010
The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cellsVesna Cerovac, Jose Monteserin-Garcia, Hadara Rubinfeld, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2006
A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responsesHava Ben-David, Badiga Venkata Aruna, Rony Seger, et al.
Pageof 15